Published in Women's Health Weekly, August 14th, 1995
The multi-centre, U.S. Phase II/III clinical trial will involve 150 evaluable patients and full patient enrollment should take approximately one year.
The company made the decision to initiate the Phase II/III clinical trial based upon a review of the data from the Phase II Canadian and German clinical trials, where the Tru-Scint AD kit was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly